Compare Stocks: OBIO, CNMD, DRTS, and STAA

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNMD CONMED	$44.43 -1.5%	$48.07	$31.44 ▼ $53.66	$1.33B	0.94	369,406 shs	400,449 shs
DRTS Alpha Tau Medical	$14.41 +2.9%	$14.44	$3.43 ▼ $15.79	$1.30B	1.22	478,503 shs	368,027 shs
OBIO Orchestra BioMed	$5.95 +3.8%	$5.37	$2.86 ▼ $6.50	$357.62M	0.52	346,922 shs	229,314 shs
STAA STAAR Surgical	$21.67 -3.2%	$22.90	$15.59 ▼ $35.87	$1.09B	1.17	1.07 million shs	591,496 shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNMD CONMED	0.00%	-4.13%	-3.62%	+15.59%	-4.48%
DRTS Alpha Tau Medical	0.00%	-2.44%	-0.21%	+13.38%	+245.56%
OBIO Orchestra BioMed	0.00%	0.00%	+2.41%	+49.12%	+105.17%
STAA STAAR Surgical	0.00%	-3.56%	-7.47%	-21.94%	-18.23%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNMD CONMED	$44.43 -1.5%	$48.07	$31.44 ▼ $53.66	$1.33B	0.94	369,406 shs	400,449 shs
DRTS Alpha Tau Medical	$14.41 +2.9%	$14.44	$3.43 ▼ $15.79	$1.30B	1.22	478,503 shs	368,027 shs
OBIO Orchestra BioMed	$5.95 +3.8%	$5.37	$2.86 ▼ $6.50	$357.62M	0.52	346,922 shs	229,314 shs
STAA STAAR Surgical	$21.67 -3.2%	$22.90	$15.59 ▼ $35.87	$1.09B	1.17	1.07 million shs	591,496 shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNMD CONMED	0.00%	-4.13%	-3.62%	+15.59%	-4.48%
DRTS Alpha Tau Medical	0.00%	-2.44%	-0.21%	+13.38%	+245.56%
OBIO Orchestra BioMed	0.00%	0.00%	+2.41%	+49.12%	+105.17%
STAA STAAR Surgical	0.00%	-3.56%	-7.47%	-21.94%	-18.23%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNMD CONMED	1.75	Reduce	$41.40	-6.82% Downside
DRTS Alpha Tau Medical	2.38	Hold	$15.40	6.87% Upside
OBIO Orchestra BioMed	2.71	Moderate Buy	$13.17	121.29% Upside
STAA STAAR Surgical	2.08	Hold	$28.45	31.31% Upside

Current Analyst Ratings Breakdown

Latest OBIO, CNMD, DRTS, and STAA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/6/2026	CNMD CONMED	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)
10/5/2026	OBIO Orchestra BioMed	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$10.00
9/29/2026	STAA STAAR Surgical	Veritas Investment Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$31.00
9/29/2026	STAA STAAR Surgical	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$28.00 ➝ $31.00
9/22/2026	STAA STAAR Surgical	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$28.00 ➝ $23.00
9/17/2026	CNMD CONMED	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
9/15/2026	OBIO Orchestra BioMed	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$10.00 ➝ $11.00
9/15/2026	OBIO Orchestra BioMed	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$10.00 ➝ $11.00
9/10/2026	OBIO Orchestra BioMed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/3/2026	DRTS Alpha Tau Medical	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$17.00 ➝ $30.00
9/2/2026	STAA STAAR Surgical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold

(Data available from 10/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNMD CONMED	$1.37B	0.97	$7.20 per share	6.17	$33.36 per share	1.33
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	$0.88 per share	N/A
OBIO Orchestra BioMed	$33.48M	10.68	N/A	N/A	$0.95 per share	6.26
STAA STAAR Surgical	$239.44M	4.54	N/A	N/A	$6.92 per share	3.13

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNMD CONMED	$47.06M	$1.85	24.02	9.39	2.03	4.12%	14.31%	6.33%	10/28/2026 (Confirmed)
DRTS Alpha Tau Medical	-$42.63M	-$1.04	N/A	N/A	N/A	N/A	-138.12%	-81.68%	11/19/2026 (Estimated)
OBIO Orchestra BioMed	-$52.70M	-$0.85	N/A	N/A	N/A	-184.60%	-149.61%	-54.15%	11/9/2026 (Estimated)
STAA STAAR Surgical	-$80.45M	$0.07	309.62	37.36	N/A	1.13%	9.05%	6.99%	11/4/2026 (Estimated)

Latest OBIO, CNMD, DRTS, and STAA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/4/2026	Q3 2026	STAA STAAR Surgical	$0.0503	N/A	N/A	N/A	$78.74 million	N/A
10/28/2026	Q3 2026	CNMD CONMED	$1.00	N/A	N/A	N/A	$336.28 million	N/A
8/12/2026	Q2 2026	STAA STAAR Surgical	$0.2214	$0.39	+$0.1686	$0.16	$90.60 million	$93.54 million
8/10/2026	Q2 2026	DRTS Alpha Tau Medical	-$0.1409	-$0.50	-$0.3591	-$0.50	$0.14 million	N/A
8/10/2026	Q2 2026	OBIO Orchestra BioMed	-$0.3920	-$0.38	+$0.0120	-$0.38	$0.14 million	$0.09 million
7/29/2026	Q2 2026	CNMD CONMED	$1.11	$1.38	+$0.27	$0.77	$337.60 million	$343.49 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNMD CONMED	N/A	N/A	-5.59%	N/A	N/A
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
OBIO Orchestra BioMed	N/A	N/A	N/A	N/A	N/A
STAA STAAR Surgical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNMD CONMED	0.63	1.48	0.69
DRTS Alpha Tau Medical	0.15	11.09	7.79
OBIO Orchestra BioMed	1.80	8.26	8.24
STAA STAAR Surgical	N/A	4.66	4.03

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNMD CONMED	N/A
DRTS Alpha Tau Medical	2.65%
OBIO Orchestra BioMed	53.20%
STAA STAAR Surgical	96.70%

Insider Ownership

Company	Insider Ownership
CNMD CONMED	0.28%
DRTS Alpha Tau Medical	39.50%
OBIO Orchestra BioMed	7.50%
STAA STAAR Surgical	39.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNMD CONMED	3,900	29.95 million	29.87 million	Optionable
DRTS Alpha Tau Medical	121	90.33 million	54.65 million	No Data
OBIO Orchestra BioMed	86	60.10 million	55.60 million	Not Optionable
STAA STAAR Surgical	957	50.14 million	30.14 million	Optionable

OBIO, CNMD, DRTS, and STAA Headlines

Recent News About These Companies

Wall Street Zen Upgrades STAAR Surgical (NASDAQ:STAA) to Buy

October 10 at 1:31 AM | americanbankingnews.com

STAAR Surgical (NASDAQ:STAA) Upgraded at Wall Street Zen

October 10 at 1:29 AM | marketbeat.com

Staar Surgical appoints Andrew Pilon as VP of business development

October 8 at 8:20 PM | streetinsider.com

Winners And Losers Of Q2: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks

October 8 at 8:20 PM | finance.yahoo.com

STAAR Surgical Names Andrew Pilon as Vice President of Business Development

October 8 at 4:00 PM | businesswire.com

STAAR Surgical Company $STAA Holdings Lifted by Two Seas Capital LP

October 6, 2026 | marketbeat.com

STAAR Surgical stock gets a USD 50 million buyback authorization

October 5, 2026 | ad-hoc-news.deA

Stifel raises target for STAAR Surgical stock to USD 31.00

October 2, 2026 | ad-hoc-news.deA

STAAR Surgical: A Recovery Story Priced As Growth

October 1, 2026 | seekingalpha.com

STAAR Surgical (NASDAQ:STAA) Stock Rating Upgraded by Stifel Nicolaus

October 1, 2026 | americanbankingnews.com

STAAR Surgical (NASDAQ:STAA) Shares Up 7.6% on Analyst Upgrade

October 1, 2026 | americanbankingnews.com

Why Staar Surgical Zoomed Almost 8% Higher on Tuesday

September 29, 2026 | fool.com

STAAR Surgical Shares Rise After Stifel Upgrade

September 29, 2026 | marketscreener.comM

STAAR Surgical analyst turns bullish on potential for 'meaningful' street upside

September 29, 2026 | msn.com

STAAR Surgical因中國市場增長潛力獲Stifel升評，股價大漲7%

September 29, 2026 | hk.finance.yahoo.com

STAAR Surgical jumps on Stifel upgrade citing China growth potential

September 29, 2026 | finance.yahoo.com

STAAR Surgical gains as Stifel upgrades to Buy on topline growth

September 29, 2026 | seekingalpha.com

This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

September 29, 2026 | benzinga.com

STAAR Surgical (NASDAQ:STAA) Shares Climb 7.6% on Analyst Upgrade

September 29, 2026 | marketbeat.com

STAAR Surgical (NASDAQ:STAA) Upgraded at Stifel Nicolaus

September 29, 2026 | marketbeat.com

Analysts Are Bullish on Top Healthcare Stocks: Staar Surgical (STAA), Xencor (XNCR)

September 27, 2026 | theglobeandmail.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

OBIO, CNMD, DRTS, and STAA Company Descriptions

CONMED NYSE:CNMD

$44.43 -0.68 (-1.51%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$44.44 +0.01 (+0.03%)

As of 10/9/2026 07:32 PM Eastern

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Alpha Tau Medical NASDAQ:DRTS

$14.41 +0.41 (+2.93%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$14.38 -0.04 (-0.24%)

As of 10/9/2026 07:44 PM Eastern

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Orchestra BioMed NASDAQ:OBIO

$5.95 +0.22 (+3.84%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$5.75 -0.20 (-3.34%)

As of 10/9/2026 07:30 PM Eastern

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

STAAR Surgical NASDAQ:STAA

$21.67 -0.71 (-3.17%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$21.50 -0.17 (-0.79%)

As of 10/9/2026 07:54 PM Eastern

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OBIO, CNMD, DRTS, and STAA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OBIO, CNMD, DRTS, and STAA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OBIO, CNMD, DRTS, and STAA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

OBIO, CNMD, DRTS, and STAA Company Descriptions

CONMED NYSE:CNMD

Alpha Tau Medical NASDAQ:DRTS

Orchestra BioMed NASDAQ:OBIO

STAAR Surgical NASDAQ:STAA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest OBIO, CNMD, DRTS, and STAA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest OBIO, CNMD, DRTS, and STAA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

OBIO, CNMD, DRTS, and STAA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

OBIO, CNMD, DRTS, and STAA Company Descriptions

CONMED NYSE:CNMD

Alpha Tau Medical NASDAQ:DRTS

Orchestra BioMed NASDAQ:OBIO

STAAR Surgical NASDAQ:STAA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools